Marine-Derived Bioactive Compounds with Potential Applications for Retinal Health
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 7
Special Issue Editor
2. Department of Ophthalmology, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
3. Medical Laser Center Lübeck, Peter-Monnik-Weg 4, 23562 Lübeck, Germany
Interests: retinal laser treatment; laser–tissue interaction; cell metabolism; oxidative stress; retinal cell/organ culture; optical coherence tomography; fluorescence lifetime imaging
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The retina is a highly specialized neural tissue essential for visual perception, and its structural and functional integrity is critical for maintaining vision. However, the retina is vulnerable to a wide range of degenerative, inflammatory, metabolic, and vascular insults that can lead to irreversible vision loss. Retinal diseases such as age-related macular degeneration and diabetic retinopathy remain major causes of blindness worldwide. While advances in diagnosis and treatment have improved outcomes, many forms of retinal degeneration still lack effective therapies, and preventive strategies remain underdeveloped.
Marine-derived bioactive compounds represent a largely untapped resource with enormous promise for retinal medicine. The ocean's unique biodiversity offers a vast array of biologically active molecules with diverse mechanisms of action and therapeutic relevance. However, this wealth of marine-derived compounds remains significantly underexplored.
The Special Issue, "Marine-Derived Bioactive Compounds with Potential Applications for Retinal Health," aims to spotlight emerging research on the use of marine compounds to support retinal structure and function. Submissions addressing therapeutic development, mechanistic studies (e.g., oxidative stress, inflammation, angiogenesis, neuroinflammation, neuroprotection or mitochondrial dysfunction), and clinical and preclinical studies evaluating the safety, efficacy, and pharmacokinetics of compounds are encouraged. Preventive strategies to maintain retinal health are also of great relevance to this topic. Studies exploring formulation and delivery approaches to enhance ocular bioavailability and interdisciplinary research contributing to this emerging field are welcome. By highlighting this underexplored field, we aim to present new avenues in vision science and retinal care inspired by marine biology.
As Guest Editor, I look forward to receiving contributions that will enrich this Special Issue and advance the field of retinal research through the lens of marine-derived compounds.
Prof. Dr. Yoko Miura
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine-derived compounds
- retina
- retinal pigment epithelium
- age-related macular degeneration
- antioxidants
- anti-inflammatory mechanisms
- neuroprotection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
